Study of L-Asparaginase, Vincristine, and Dexamethasone Combined With Intensity-modulated Radiation Therapy in Early-Stage Nasal NK/T-Cell Lymphoma
Conclusion: In patients with early-stage nasal NKTCL, our LVD-IMRT regimen produced excellent, durable therapeutic benefit in most patients, with acceptable toxicity and no acute mortality.
Publication date: Available online 30 May 2020Source: Journal of the Formosan Medical AssociationAuthor(s): Jia-Kang Wang, Tzu-Lun Huang, Pei-Yao Chang
Publication date: Available online 30 May 2020Source: Annals of Medicine and SurgeryAuthor(s): Nariman Khan, Andrew Donati, Collin Clay
Publication date: Available online 30 May 2020Source: Microbial PathogenesisAuthor(s): Si-Yang Huang, Yi-Min Fan, Na Yao, Yi Yang, Ming-Yu Pei, Yi-Jun Ren, Jing-Zhi Gong
Authors: Li Y, Du L, Tang X, Chen Y, Mei D Abstract BACKGROUND: Rivaroxaban, a novel oral anticoagulant drug, is widely used in clinical practice. There is no standardized laboratory monitoring for rivaroxaban, and its plasma concentration in Chinese patients with deep vein thrombosis is unclear. The rivaroxaban concentrations in human plasma and determine the steady-state concentration of rivaroxaban in patients with deep vein thrombosis are needed. METHODS: An ultra-high-performance liquid chromatography with mass spectrometric detection method was developed. Chromatographic separation was performed on a Wate...
Publication date: Available online 30 April 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Alessandra Malato, Elena Rossi, Mario Tiribelli, Francesco Mendicino, Novella Pugliese
Publication date: Available online 30 May 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): John C. Carlson
Publication date: Available online 30 May 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Adeeb B. Bulkhi, Kirk V. Shepard, Thomas B. Casale, Juan Carlos Cardet
Authors: Cappannoli L, Scacciavillani R, Iannaccone G, Anastasia G, Di Giusto F, Crea F Abstract From first cases reported on December 31, 2019, in Wuhan, Hubei-China, SARS-CoV2 has spread worldwide and finally the World Health Organization declared the pandemic status. We summarize what makes SARS-CoV2 different from previous highly pathogenic coronaviruses and why it is so contagious, with focus on its clinical presentation and diagnosis, which is mandatory to start the appropriate management and reduce the transmission. As far as infection pathophysiology is still not completely clarified, this review focuses al...
Pembrolizumab outperformed chemotherapy in patients with microsatellite-instability high/mismatch repair-deficient metastatic colorectal cancer in the KEYNOTE-177 study.Medscape Medical News
Publication date: Available online 30 May 2020Source: Stem Cell ResearchAuthor(s): Liang Shi, Yazhou Cui, Zijuan Qi, Xiaoyan Zhou, Jing Luan, Jinxiang Han